Literature DB >> 27025457

Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling.

Astrid Slany1, Andrea Bileck1, Dominique Kreutz1, Rupert L Mayer1, Besnik Muqaku1, Christopher Gerner2.   

Abstract

In order to systematically analyze proteins fulfilling effector functionalities during inflammation, here we present a comprehensive proteome study of inflammatory activated primary human endothelial cells and fibroblasts. Cells were stimulated with interleukin 1-β and fractionated in order to obtain secreted, cytoplasmic and nuclear protein fractions. Proteins were submitted to a data-dependent bottom up analytical platform using a QExactive orbitrap and the MaxQuant software for protein identification and label-free quantification. Results were further combined with similarly generated data previously obtained from the analysis of inflammatory activated peripheral blood mononuclear cells. Applying a false discovery rate of less than 0.01 at both, peptide and protein level, a total of 8370 protein groups assembled from 117,599 peptides was identified; mass spectrometry data have been made fully accessible via ProteomeXchange with identifier PXD003406 to PXD003417.Comparative proteome analysis allowed us to determine common and cell type-specific inflammation signatures comprising novel candidate marker molecules and related expression patterns of transcription factors. Cardinal features of inflammation such as interleukin 1-β processing and the interferon response differed substantially between the investigated cells. Furthermore, cells also exerted similar inflammation-related tasks; however, by making use of different sets of proteins. Hallmarks of inflammation thus emerged, including angiogenesis, extracellular matrix reorganization, adaptive and innate immune responses, oxidative stress response, cell proliferation and differentiation, cell adhesion and migration in addition to monosaccharide metabolic processes, representing both, common and cell type-specific responsibilities of cells during inflammation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27025457      PMCID: PMC5083104          DOI: 10.1074/mcp.M116.058099

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  68 in total

Review 1.  Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy.

Authors:  Eeva-Liisa Eskelinen
Journal:  Mol Aspects Med       Date:  2006-09-14

2.  Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM.

Authors:  Mark Aitkenhead; Shur-Jen Wang; Martin N Nakatsu; Javier Mestas; Cheryl Heard; Christopher C W Hughes
Journal:  Microvasc Res       Date:  2002-03       Impact factor: 3.514

3.  Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway.

Authors:  Sarah M Battcock; Thaddeus W Collier; Dong Zu; Kensuke Hirasawa
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 4.  Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.

Authors:  Matthew T Holderfield; Christopher C W Hughes
Journal:  Circ Res       Date:  2008-03-28       Impact factor: 17.367

5.  Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.

Authors:  Keiichiro Tanaka; Noriko Hiraiwa; Hisashi Hashimoto; Yoji Yamazaki; Moriaki Kusakabe
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

6.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

7.  Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

Authors:  M Mura; R K Swain; X Zhuang; H Vorschmitt; G Reynolds; S Durant; J F J Beesley; J M J Herbert; H Sheldon; M Andre; S Sanderson; K Glen; N-T Luu; H M McGettrick; P Antczak; F Falciani; G B Nash; Z S Nagy; R Bicknell
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

Review 8.  Inflammation and cancer: advances and new agents.

Authors:  Shanthini M Crusz; Frances R Balkwill
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

Review 9.  Biglycan: a multivalent proteoglycan providing structure and signals.

Authors:  Madalina V Nastase; Marian F Young; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2012-07-20       Impact factor: 2.479

Review 10.  Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.

Authors:  Roman Fischer; Olaf Maier
Journal:  Oxid Med Cell Longev       Date:  2015-03-05       Impact factor: 6.543

View more
  19 in total

1.  Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.

Authors:  Besnik Muqaku; Martin Eisinger; Samuel M Meier; Ammar Tahir; Tobias Pukrop; Sebastian Haferkamp; Astrid Slany; Albrecht Reichle; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2016-11-22       Impact factor: 5.911

2.  Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia.

Authors:  Lukas Janker; Rupert L Mayer; Andrea Bileck; Dominique Kreutz; Johanna C Mader; Kirsten Utpatel; Daniel Heudobler; Hermine Agis; Christopher Gerner; Astrid Slany
Journal:  Mol Cell Proteomics       Date:  2019-02-21       Impact factor: 5.911

3.  Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Authors:  Verena Paulitschke; Ossia Eichhoff; Christopher Gerner; Philipp Paulitschke; Andrea Bileck; Thomas Mohr; Phil F Cheng; Alexander Leitner; Emmanuella Guenova; Ieva Saulite; Sandra N Freiberger; Anja Irmisch; Bernhard Knapp; Nina Zila; Theodora-Pagona Chatziisaak; Jürgen Stephan; Joanna Mangana; Rainer Kunstfeld; Hubert Pehamberger; Ruedi Aebersold; Reinhard Dummer; Mitchell P Levesque
Journal:  EMBO J       Date:  2019-06-26       Impact factor: 11.598

4.  Combined transcriptome and proteome profiling reveals specific molecular brain signatures for sex, maturation and circalunar clock phase.

Authors:  Sven Schenk; Stephanie C Bannister; Fritz J Sedlazeck; Dorothea Anrather; Bui Quang Minh; Andrea Bileck; Markus Hartl; Arndt von Haeseler; Christopher Gerner; Florian Raible; Kristin Tessmar-Raible
Journal:  Elife       Date:  2019-02-15       Impact factor: 8.140

5.  A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.

Authors:  John Silke; Ueli Nachbur; Valentin J Heim; Laura F Dagley; Che A Stafford; Fynn M Hansen; Elise Clayer; Aleksandra Bankovacki; Andrew I Webb; Isabelle S Lucet
Journal:  EMBO Rep       Date:  2020-09-21       Impact factor: 8.807

6.  Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis.

Authors:  Thomas Mohr; Verena Haudek-Prinz; Astrid Slany; Johannes Grillari; Michael Micksche; Christopher Gerner
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

7.  Deoxynivalenol induces structural alterations in epidermoid carcinoma cells A431 and impairs the response to biomechanical stimulation.

Authors:  Giorgia Del Favero; Lydia Woelflingseder; Lukas Janker; Benjamin Neuditschko; Stefano Seriani; Paolo Gallina; Orfeo Sbaizero; Christopher Gerner; Doris Marko
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

8.  Proteomic profiling identifies markers for inflammation-related tumor-fibroblast interaction.

Authors:  Daniel Drev; Andrea Bileck; Christopher Gerner; Brigitte Marian; Zeynep N Erdem; Thomas Mohr; Gerald Timelthaler; Andrea Beer
Journal:  Clin Proteomics       Date:  2017-10-06       Impact factor: 3.988

9.  Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

Authors:  Nina Zila; Andrea Bileck; Besnik Muqaku; Lukas Janker; Ossia M Eichhoff; Phil F Cheng; Reinhard Dummer; Mitchell P Levesque; Christopher Gerner; Verena Paulitschke
Journal:  Clin Proteomics       Date:  2018-03-09       Impact factor: 3.988

10.  Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice.

Authors:  Ursula J Lemberger; Claudia D Fuchs; Christian Schöfer; Andrea Bileck; Christopher Gerner; Tatjana Stojakovic; Makoto M Taketo; Michael Trauner; Gerda Egger; Christoph H Österreicher
Journal:  Oncotarget       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.